<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
      <journal-id journal-id-type="publisher-id">J CLIN INVEST</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Clinical Investigation</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0021-9738</issn>
      <issn pub-type="epub">1558-8238</issn>
      <publisher>
        <publisher-name>American Society for Clinical Investigation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25705884</article-id>
      <article-id pub-id-type="pmc">4396490</article-id>
      <article-id pub-id-type="publisher-id">79329</article-id>
      <article-id pub-id-type="doi">10.1172/JCI79329</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Caspase-1–mediated pathway promotes generation of thromboinflammatory microparticles</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rothmeier</surname>
            <given-names>Andrea S.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marchese</surname>
            <given-names>Patrizia</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Petrich</surname>
            <given-names>Brian G.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Furlan-Freguia</surname>
            <given-names>Christian</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ginsberg</surname>
            <given-names>Mark H.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruggeri</surname>
            <given-names>Zaverio M.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruf</surname>
            <given-names>Wolfram</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Immunology and Microbial Science and</aff>
      <aff id="A2"><label>2</label>Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA.</aff>
      <aff id="A3"><label>3</label>School of Medicine, Emory University, Atlanta, Georgia, USA.</aff>
      <aff id="A4"><label>4</label>Department of Medicine, UCSD, La Jolla, California, USA.</aff>
      <aff id="A5"><label>5</label>Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany.</aff>
      <author-notes>
        <corresp>Address correspondence to: Wolfram Ruf, Department of Immunology and Microbial Science, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA. Phone: 858.784.2784; E-mail: <email>ruf@scripps.edu</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>2</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>1</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 3 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
      <volume>125</volume>
      <issue>4</issue>
      <fpage>1471</fpage>
      <lpage>1484</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2015, American Society for Clinical Investigation</copyright-statement>
        <copyright-year>2015</copyright-year>
        <copyright-holder>American Society for Clinical Investigation</copyright-holder>
      </permissions>
      <abstract>
        <p>Extracellular ATP is a signal of tissue damage and induces macrophage responses that amplify inflammation and coagulation. Here we demonstrate that ATP signaling through macrophage P2X7 receptors uncouples the thioredoxin (TRX)/TRX reductase (TRXR) system and activates the inflammasome through endosome-generated ROS. TRXR and inflammasome activity promoted filopodia formation, cellular release of reduced TRX, and generation of extracellular thiol pathway–dependent, procoagulant microparticles (MPs). Additionally, inflammasome-induced activation of an intracellular caspase-1/calpain cysteine protease cascade degraded filamin, thereby severing bonds between the cytoskeleton and tissue factor (TF), the cell surface receptor responsible for coagulation activation. This cascade enabled TF trafficking from rafts to filopodia and ultimately onto phosphatidylserine-positive, highly procoagulant MPs. Furthermore, caspase-1 specifically facilitated cell surface actin exposure, which was required for the final release of highly procoagulant MPs from filopodia. Together, the results of this study delineate a thromboinflammatory pathway and suggest that components of this pathway have potential as pharmacological targets to simultaneously attenuate inflammation and innate immune cell–induced thrombosis.</p>
      </abstract>
    </article-meta>
  </front>
</article>

